A population-based study on the seroepidemiology of varicella zoster virus among children and adolescents in Fujian, China
- 1Fujian Provincial Key Laboratory of Zoonosis Research, Fujian Center for Disease Control and Prevention, Fuzhou, 350001 China
Abstract
Background: Varicella continues to pose a significant public health challenge for children and adolescents in China. Although vaccination is available, the disease remains highly prevalent among children in Fujian. This study aimed to evaluate the seroepidemiology of varicella-zoster virus (VZV) and to explore the factors contributing to its high incidence in individuals aged 0–17 years.
Methods: A cross-sectional serosurvey was conducted in 2023. Serum samples from 2,675 eligible individuals were tested for VZV IgG using ELISA. Demographic and vaccination data were collected via questionnaire.
Results: A total of 2,675 participants, aged between 2 days and 17 years with a median age of 6.5 years, were included. The overall seropositivity rate of VZV IgG was 47.7% (95% CI: 45.5–49.3), with a geometric mean concentration (GMC) of 81.3 mIU/mL (95% CI: 77.0–85.9). Marked variations in these immunity markers were observed across age groups, genders, and vaccination statuses. Notably, varicella vaccination coverage was substantially low: only 54.9% of children aged 1–17 years had received one dose, and merely 17.4% were fully vaccinated with two doses. A clear post-vaccination antibody waning pattern was also evident. Both seropositivity rate and GMC began to decline one year after vaccination, decreasing by more than 50% after four years.
Conclusions: The seropositivity rates and GMC of varicella antibodies were low among individuals aged 0–17 years in Fujian Province, and vaccination coverage was insufficient, particularly for the second dose (< 20%). Antibody titers declined markedly over time, which may be partly associated with the high incidence of varicella in this region. To ensure the continuity of surveillance data, further efforts are needed to strengthen epidemiological surveillance of varicella in younger age groups and to promote the timeliness and completeness of vaccination.
Clinical trial number: Not applicable.
Related
- Assessing the Age-Specific Seroepidemiology of Varicella-Zoster Virus in Korea in the Post-COVID-19 Era Using an Acetone-Fixed Cell FAMA Assay
- Longitudinal Evaluation of Serum Varicella-zoster Virus Viral Load in a Woman with Systemic Lupus Erythematosus Complicated by a Visceral Disseminated Varicella-zoster Virus Infection: A Case Report
- Disseminated Varicella-Zoster Virus Infection Following a Live Attenuated Varicella Vaccine (Oka Strain) in a Patient with Rheumatoid Arthritis: A Case Report
- Varicella-Zoster Virus Vasculopathy with Extension from the Cranial Nerves to the Brainstem: A Case Report
- Successful Treatment of Varicella Zoster Encephalitis in a Sarcopenic Obese Patient after Acyclovir-induced Acute Kidney Injury: The Necessity of Individualized Dosing
BibTeX
@article{li2026populationbased,
title = {{A population-based study on the seroepidemiology of varicella zoster virus among children and adolescents in Fujian, China}},
author = {Dong Li and Zhifei Chen and Hairong Zhang and Suhan Zhang and Mengping Zhang and Xiuhui Yang and Xiaoling Chu and Dongjuan Zhang},
journal = {BMC Infectious Diseases},
year = {2026},
month = aug,
doi = {10.1186/s12879-026-13917-z},
url = {https://doi.org/10.1186/s12879-026-13917-z},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A population-based study on the seroepidemiology of varicella zoster virus among children and adolescents in Fujian, China
AU - Dong Li
AU - Zhifei Chen
AU - Hairong Zhang
AU - Suhan Zhang
AU - Mengping Zhang
AU - Xiuhui Yang
AU - Xiaoling Chu
AU - Dongjuan Zhang
PY - 2026
DA - 2026/08/06
JO - BMC Infectious Diseases
DO - 10.1186/s12879-026-13917-z
UR - https://doi.org/10.1186/s12879-026-13917-z
AB - Background: Varicella continues to pose a significant public health challenge for children and adolescents in China. Although vaccination is available, the disease remains highly prevalent among children in Fujian. This study aimed to evaluate the seroepidemiology of varicella-zoster virus (VZV) and to explore the factors contributing to its high incidence in individuals aged 0–17 years. Methods: A cross-sectional serosurvey was conducted in 2023. Serum samples from 2,675 eligible individuals were tested for VZV IgG using ELISA. Demographic and vaccination data were collected via questionnaire. Results: A total of 2,675 participants, aged between 2 days and 17 years with a median age of 6.5 years, were included. The overall seropositivity rate of VZV IgG was 47.7% (95% CI: 45.5–49.3), with a geometric mean concentration (GMC) of 81.3 mIU/mL (95% CI: 77.0–85.9). Marked variations in these immunity markers were observed across age groups, genders, and vaccination statuses. Notably, varicella vaccination coverage was substantially low: only 54.9% of children aged 1–17 years had received one dose, and merely 17.4% were fully vaccinated with two doses. A clear post-vaccination antibody waning pattern was also evident. Both seropositivity rate and GMC began to decline one year after vaccination, decreasing by more than 50% after four years. Conclusions: The seropositivity rates and GMC of varicella antibodies were low among individuals aged 0–17 years in Fujian Province, and vaccination coverage was insufficient, particularly for the second dose (< 20%). Antibody titers declined markedly over time, which may be partly associated with the high incidence of varicella in this region. To ensure the continuity of surveillance data, further efforts are needed to strengthen epidemiological surveillance of varicella in younger age groups and to promote the timeliness and completeness of vaccination. Clinical trial number: Not applicable.
SN - 1471-2334
ER -